查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1803053

2032 年数位安慰剂效应市场预测：按干预类型、技术、交付管道、应用、最终用户和地区进行的全球分析

Digital Placebo Effect Market Forecasts to 2032 - Global Analysis By Intervention Type, Technology, Delivery Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球数位安慰剂效应市场预计在 2025 年达到 5.475 亿美元，到 2032 年将达到 10.3343 亿美元，预测期内的复合年增长率为 9.5%。

数位安慰剂效应是指个人在使用数位健康工具、应用程式和设备后体验到的心理和生理改善，即使这些技术本身并未提供积极的治疗性介入。这种效应源自于使用者的期望、感知到的信任以及对科技的参与，从而提升了幸福感并缓解了症状。与传统的安慰剂效应类似，它强调了信念、动机和使用者互动在透过数位解决方案推动可衡量的健康结果方面所发挥的作用。

对数位健康解决方案的需求不断增长

数位健康应用的激增，引发了人们对基于安慰剂的数位干预措施的好奇，这些措施利用用户的信念来推动实际疗效。随着应用程式、穿戴式装置和虚拟疗法的日益普及，人们逐渐认识到感知疗效具有心理效应。人们越来越愿意接受非药物解决方案，尤其是那些提供客製化回馈和参与度的解决方案。数位安慰剂效应是指使用者仅透过信任科技就能获得真正的益处，而这种效应正在心理健康、慢性疼痛和生活方式管理等领域中研究。这种转变促使开发人员设计出能够增强使用者信任和参与度的介面。行为心理学与数位疗法的融合正在推动市场成长。

缺乏标准化的定义和规定

在数位安慰剂效应领域，缺乏统一的定义或正式的监管规定限制了其合法性和长期可行性。模糊的界线使企业得以夸大其健康益处，引发伦理争议并造成混乱。缺乏一致的语言规范阻碍了相关人员之间的合作与协调。监管的不确定性阻碍了资金筹措并扼杀了创新。缺乏连贯的框架，市场可能会出现碎片化，临床应用也会受到限制。

融入更广泛的医疗保健生态系统

将数位安慰剂技术融入现有医疗平台，可提升病患参与度与治疗效果。透过将安慰剂增强功能融入远端医疗、行动医疗应用程式和穿戴式设备，医疗服务提供者无需依赖药物即可增强治疗效果。这些工具可以作为传统疗法的补充，提供低风险、经济高效的治疗方案。与健康记录和远端监控系统的整合，可以根据个人需求客製化个人化的安慰剂策略。随着医疗保健逐渐转向更全面、以患者为中心的模式，数位安慰剂提供了一个引人注目的新维度，为行为和预防保健领域的创新创造了肥沃的土壤。

来自传统药物的威胁

成熟的药物疗法对数位安慰剂构成挑战，尤其是在临床效果已被验证的领域。患者和临床医生都可能不愿意接受这种基于信仰而非生物化学原理的干预措施。缺乏活性成分可能会引发怀疑，尤其是在严重或急性疾病。製药公司可能认为数位安慰剂具有颠覆性，并抵制其应用。此外，保险政策通常更倾向于传统治疗方法，这使得数位安慰剂工具难以获得资金支持。这些动态可能会阻碍其被接受，并减缓市场扩张。

COVID-19的影响：

疫情加速了远端医疗的转变，并间接增加了人们对数位安慰剂解决方案的兴趣。由于无法获得面对面的医疗服务，使用者转向了能够提供安慰和治疗价值的虚拟平台。这一趋势凸显了信念和期望在健康结果中发挥重要作用，尤其是在心理和情绪健康方面。开发人员为此添加了引导式视觉化、激励提示和身临其境型设计等功能，以增强安慰剂效应。然而，这场危机也暴露了这些工具在监管和科学严谨性方面存在的不足。

习惯和辅导应用程式细分市场预计将在预测期内成为最大的细分市场

在人工智慧主导製化、行为设计和游戏化策略的推动下，习惯和辅导类应用预计将在预测期内占据最大的市场占有率。值得关注的趋势包括：结合自学工具和即时辅导的混合模式、行动优先的介面以及可扩展的云端基础设施。关键的进步包括机器学习技术，能够实现即时回馈，以及对心理健康和生产力的日益关注。疫情导致远距个人发展需求激增，促使各组织采用数位化辅导来提升领导力、提高员工敬业度和绩效。

预计预测期内 CRO 和製药领域将出现最高复合年增长率

预计在预测期内，CRO 和製药业将实现最高成长率，这得益于人工智慧驱动的研究设计、分散式研究模型和客製化研究。目前的趋势着重于以患者为先的方法、真实世界证据的整合以及灵活的混合试验。关键创新包括基于机器学习的预测分析、透过云端平台进行远端监控以及用于结果追踪的数位生物标记。随着药物开发日益复杂，製药公司越来越依赖精通技术的 CRO 来简化流程、降低成本并更灵活地应对不断变化的监管需求。

占比最大的地区：

预计亚太地区将在预测期内占据最大市场占有率，这得益于人工智慧、物联网和穿戴式技术的广泛应用，这些技术将有助于个人化医疗解决方案的实现。核心技术包括云端基础平台、数位生物标记物和即时数据分析。关键趋势包括去中心化临床模式、行动优先的健康应用和以使用者为中心的数位疗法。近期发展突显了监管参与度的不断提升、製药公司与合约研究组织 (CRO) 之间的策略联盟，以及对心理健康、慢性病管理和不同人群行为指导领域可扩展且经济实惠的创新的大力推动。

复合年增长率最高的地区：

预计北美将在预测期内呈现最高的复合年增长率，这得益于尖端人工智慧、数位表型分析以及专为临床和行为应用而设计的远端监控技术。突出的趋势包括虚拟辅导解决方案、分散式试验模式以及使用真实​​世界数据检验结果。近期的进展包括云端基础的可扩展交付基础设施、对数位疗法的监管响应增强，以及製药公司与合约研究组织 (CRO) 之间合作的深化。该地区强劲的创新格局和医疗保健体系将继续推动个人化、技术驱动的干预措施。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球数位安慰剂效应市场（依干预类型）

  • 移动微干预
    • 习惯和指导应用程式
    • 一款增强专注力和预期能力的应用程式
    • 症状追踪和反馈应用程式
  • 对话代理
    • 基于规则的聊天机器人
    • 语音助理
    • 基于AI/LLM的伴侣
  • 身临其境型与多感官
    • 虚拟实境（VR）
    • 视听神经调节工具
    • 扩增实境/混合实境（AR/MR）
  • 穿戴式装置和生物回馈疗法
    • 腕带和戒指设备
    • 神经反馈/HRV工具
    • 触觉和经皮神经电刺激 (TENS) 等消费性设备
  • 研究的安慰剂对照
    • 虚假应用程式的条件
    • 期望一致性通讯协定
    • 注意力控制介面

6. 全球数位安慰剂效应市场（按技术）

  • 数字模态
    • 行动医疗应用程式
    • 穿戴式装置和生物感测器
    • 远端医疗平台
  • 身临其境型技术堆迭
    • VR/AR硬体
    • 神经调节介面
  • 行为设计
    • 游戏化
    • 回馈迴路
    • 加固系统
  • AI个人化
    • 自适应演算法
    • 期望模型
    • 基于NLP的定制

7. 全球数位安慰剂效应市场（按分销管道）

  • 基于应用程式的干预措施
  • 基于聊天机器人/简讯
  • 网路为基础的平台
  • 身临其境型介面

第八章全球数位安慰剂效应市场（按应用）

  • 心理健康
  • 慢性疼痛管理
  • 睡眠和压力干预
  • 提升认知能力
  • 其他用途

9. 全球数位安慰剂效应市场（依最终用户）

  • 病人和消费者
  • 医疗保健提供者
  • 研究机构
  • 付款人和保险公司
  • CRO和製药公司
  • 其他最终用户

第 10 章全球数位安慰剂效应市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Pear Therapeutics
  • BioBeats
  • Happify Health
  • TheraVR
  • Akili Interactive
  • Emteq Labs
  • Big Health
  • Somatix
  • Woebot Health
  • BreatheVR
  • MindMaze
  • Neuroelectrics
  • Kaia Health
  • Cognoa
  • Click Therapeutics
  • Flow Neuroscience
  • BehaVR
  • Limbix
Product Code: SMRC30578

According to Stratistics MRC, the Global Digital Placebo Effect Market is accounted for $547.50 million in 2025 and is expected to reach $1033.43 million by 2032 growing at a CAGR of 9.5% during the forecast period. The Digital Placebo Effect refers to the psychological and physiological improvements individuals experience from using digital health tools, apps, or devices, even when these technologies provide no active therapeutic intervention. This effect arises from user expectations, perceived credibility, and engagement with the technology, leading to enhanced well-being or symptom relief. Similar to traditional placebo effects, it highlights the role of belief, motivation, and user interaction in driving measurable health outcomes through digital solutions.

Market Dynamics:

Driver:

Growing demand for digital health solutions

The surge in digital health adoption is sparking curiosity around placebo-based digital interventions that harness user belief to drive real outcomes. As apps, wearables, and virtual therapies become more common, the psychological impact of perceived effectiveness is gaining recognition. People are increasingly open to non-drug solutions, especially those offering tailored feedback and engagement. Digital placebo effects where users experience real benefits simply by trusting the technology are being explored in areas like mental wellness, chronic pain, and lifestyle management. This shift is motivating developers to design interfaces that reinforce user confidence and involvement. The fusion of behavioral psychology with digital therapeutics is accelerating market growth.

Restraint:

Lack of standardized definitions and regulations

A lack of unified definitions and formal regulations in the Digital Placebo Effect space is restraining its legitimacy and long-term viability. Vague boundaries allow firms to exaggerate health benefits, raising ethical red flags and spreading confusion. The absence of consistent language disrupts collaboration and makes it harder for stakeholders to align. Regulatory uncertainty discourages funding and stifles innovation, while eroding public confidence in digital placebo tools. Without a coherent framework, the market risks fragmentation and limited adoption in clinical settings.

Opportunity:

Integration into broader healthcare ecosystems

Digital placebo technologies could be woven into existing healthcare platforms to enhance patient engagement and outcomes. By incorporating placebo-enhancing features into telemedicine, mobile health apps, and wearable devices, providers can amplify therapeutic effects without relying on medication. These tools can serve as supportive layers alongside conventional treatments, offering low-risk and cost-effective options. Integration with health records and remote monitoring systems allows for personalized placebo strategies tailored to individual needs. As healthcare moves toward more holistic and patient-centric models, digital placebos offer a compelling new dimension. This creates fertile ground for innovation in behavioral health and preventive care.

Threat:

Threat from traditional therapeutics

Established drug-based treatments pose a challenge to the digital placebo, especially in areas with proven clinical outcomes. Both patients and clinicians may be hesitant to embrace interventions that rely on belief rather than biochemical action. The absence of active ingredients can lead to skepticism, particularly for serious or acute conditions. Pharmaceutical companies may view digital placebos as disruptive and resist their adoption. Additionally, insurance policies often favor traditional therapies, making it harder for digital placebo tools to gain financial support. These dynamics could hinder acceptance and slow market expansion.

Covid-19 Impact:

The pandemic accelerated the shift to remote care, indirectly boosting interest in digital placebo solutions. With limited access to in-person services, users turned to virtual platforms that offered reassurance and perceived therapeutic value. This trend highlighted how belief and expectation can play a powerful role in health outcomes, especially in mental and emotional well-being. Developers responded by adding features like guided visualization, motivational cues, and immersive design to enhance placebo effects. However, the crisis also revealed gaps in oversight and scientific rigor for these tools.

The habit & coaching apps segment is expected to be the largest during the forecast period

The habit & coaching apps segment is expected to account for the largest market share during the forecast period, propelled by AI-driven customization, behavioural design, and Gamification strategies. Notable trends include hybrid models combining self-guided tools with live coaching, mobile-first interfaces, and scalable cloud infrastructure. Key advancements involve machine learning for real-time feedback and growing interest in mental health and productivity enhancement. The pandemic catalyzed a surge in remote self-improvement, prompting organizations to adopt digital coaching for leadership development, employee engagement, and performance enhancement.

The CROs & pharma segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the CROs & pharma segment is predicted to witness the highest growth rate, driven by AI-enabled trial design, decentralized research models, and tailored therapeutics. Current trends highlight patient-first approaches, integration of real-world evidence, and flexible hybrid trials. Key innovations include predictive analytics via machine learning, remote monitoring through cloud platforms, and digital biomarkers for tracking outcomes. As drug development grows more complex, pharma increasingly relies on tech-savvy CROs to streamline processes, cut costs, and meet evolving regulatory demands with greater agility.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to widespread adoption of AI, IoT, and wearable technologies that enable personalized health solutions. Core technologies include cloud-based platforms, digital biomarkers, and real-time data analytics. Key trends involve decentralized clinical models, mobile-first wellness applications, and user-centric digital therapeutics. Recent developments highlight growing regulatory engagement, strategic collaborations between pharma and CROs, and a strong push toward scalable, affordable innovations in mental health, chronic disease management, and behavioural coaching across diverse populations.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by cutting-edge AI, digital phenotyping, and remote monitoring technologies designed for clinical and behavioural applications. Prominent trends include virtual coaching solutions, decentralized trial formats, and the use of real-world data to validate outcomes. Recent advancements feature cloud-based infrastructure for scalable delivery, growing regulatory alignment with digital therapeutics, and deeper collaboration between pharmaceutical firms and CROs. The region's strong innovation landscape and healthcare systems continue to drive personalized, tech-enabled interventions.

Key players in the market

Some of the key players in Digital Placebo Effect Market include Pear Therapeutics, BioBeats, Happify Health, TheraVR, Akili Interactive, Emteq Labs, Big Health, Somatix, Woebot Health, BreatheVR, MindMaze, Neuroelectrics, Kaia Health, Cognoa, Click Therapeutics, Flow Neuroscience, BehaVR, and Limbix.

Key Developments:

In July 2022, Big Health has acquired Limbix, creators of the first, evidence-based digital therapeutic for teens and young adults with symptoms of depression. Since its founding in 2016, Limbix has raised $30 million through its Series A funding round and has built a research-based pipeline of adolescent products.

In July 2022, Biobeat announces its newest partner M-ighty in the Belgian Market. Biobeat's expansion in the Belgian market gains momentum with the exciting collaboration with their latest partner, M-ighty. This strategic partnership has been established to enhance the presence of Biobeat's cutting-edge monitoring system in Belgium's healthcare landscape. The announcement marks a significant step forward in Biobeat's mission to provide innovative solutions for clinical patient care and remote patient monitoring.

In May 2020, SOMATEX introduces the Lung Marker System in the US. Recently FDA listed, the tried and tested lung tissue marker enables secure localization of smaller, non-superficial pulmonary nodules. "We are excited to launch our product in the US to fulfill the growing market need for lung tumor localization," says Dan Furnas, Vice President Sales at SOMATEX USA.

Intervention Types Covered:

  • Mobile Micro-interventions
  • Conversational Agents
  • Immersive & Multisensory
  • Wearables & Biofeedback
  • Placebo Controls for Trials

Technologies Covered:

  • Digital Modalities
  • Immersive Tech Stack
  • Behavioral Design
  • AI Personalization

Delivery Channels Covered:

  • App-based interventions
  • Chatbot/SMS-based
  • Web-based platforms
  • Immersive Interfaces

Applications Covered:

  • Mental health
  • Chronic pain management
  • Sleep and stress interventions
  • Cognitive enhancement
  • Other Applications

End Users Covered:

  • Patients & Consumers
  • Healthcare providers
  • Research institutions
  • Payers and insurers
  • CROs & Pharma
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Placebo Effect Market, By Intervention Type

  • 5.1 Introduction
  • 5.2 Mobile Micro-interventions
    • 5.2.1 Habit & Coaching Apps
    • 5.2.2 Mindfulness & Expectation-Priming Apps
    • 5.2.3 Symptom Tracking & Feedback Apps
  • 5.3 Conversational Agents
    • 5.3.1 Rule-based Chatbots
    • 5.3.2 Voice Assistants
    • 5.3.3 AI/LLM-based Companions
  • 5.4 Immersive & Multisensory
    • 5.4.1 Virtual Reality (VR)
    • 5.4.2 Audio-visual Neuromodulation Tools
    • 5.4.3 Augmented/Mixed Reality (AR/MR)
  • 5.5 Wearables & Biofeedback
    • 5.5.1 Wrist & Ring Devices
    • 5.5.2 Neurofeedback/HRV Tools
    • 5.5.3 Haptics & TENS-like Consumer Devices
  • 5.6 Placebo Controls for Trials
    • 5.6.1 Sham App Conditions
    • 5.6.2 Expectancy-Matched Protocols
    • 5.6.3 Attentional Control Interfaces

6 Global Digital Placebo Effect Market, By Technology

  • 6.1 Introduction
  • 6.2 Digital Modalities
    • 6.2.1 Mobile health apps
    • 6.2.2 Wearable devices and biosensors
    • 6.2.3 Telemedicine platforms
  • 6.3 Immersive Tech Stack
    • 6.3.1 VR/AR hardware
    • 6.3.2 Neuromodulation interfaces
  • 6.4 Behavioral Design
    • 6.4.1 Gamification
    • 6.4.2 Feedback loops
    • 6.4.3 Reinforcement systems
  • 6.5 AI Personalization
    • 6.5.1 Adaptive algorithms
    • 6.5.2 Expectancy modeling
    • 6.5.3 NLP-based tailoring

7 Global Digital Placebo Effect Market, By Delivery Channel

  • 7.1 Introduction
  • 7.2 App-based interventions
  • 7.3 Chatbot/SMS-based
  • 7.4 Web-based platforms
  • 7.5 Immersive Interfaces

8 Global Digital Placebo Effect Market, By Application

  • 8.1 Introduction
  • 8.2 Mental health
  • 8.3 Chronic pain management
  • 8.4 Sleep and stress interventions
  • 8.5 Cognitive enhancement
  • 8.6 Other Applications

9 Global Digital Placebo Effect Market, By End User

  • 9.1 Introduction
  • 9.2 Patients & Consumers
  • 9.3 Healthcare providers
  • 9.4 Research institutions
  • 9.5 Payers and insurers
  • 9.6 CROs & Pharma
  • 9.7 Other End Users

10 Global Digital Placebo Effect Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Pear Therapeutics
  • 12.2 BioBeats
  • 12.3 Happify Health
  • 12.4 TheraVR
  • 12.5 Akili Interactive
  • 12.6 Emteq Labs
  • 12.7 Big Health
  • 12.8 Somatix
  • 12.9 Woebot Health
  • 12.10 BreatheVR
  • 12.11 MindMaze
  • 12.12 Neuroelectrics
  • 12.13 Kaia Health
  • 12.14 Cognoa
  • 12.15 Click Therapeutics
  • 12.16 Flow Neuroscience
  • 12.17 BehaVR
  • 12.18 Limbix

List of Tables

  • Table 1 Global Digital Placebo Effect Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Digital Placebo Effect Market Outlook, By Intervention Type (2024-2032) ($MN)
  • Table 3 Global Digital Placebo Effect Market Outlook, By Mobile Micro-interventions (2024-2032) ($MN)
  • Table 4 Global Digital Placebo Effect Market Outlook, By Habit & Coaching Apps (2024-2032) ($MN)
  • Table 5 Global Digital Placebo Effect Market Outlook, By Mindfulness & Expectation-Priming Apps (2024-2032) ($MN)
  • Table 6 Global Digital Placebo Effect Market Outlook, By Symptom Tracking & Feedback Apps (2024-2032) ($MN)
  • Table 7 Global Digital Placebo Effect Market Outlook, By Conversational Agents (2024-2032) ($MN)
  • Table 8 Global Digital Placebo Effect Market Outlook, By Rule-based Chatbots (2024-2032) ($MN)
  • Table 9 Global Digital Placebo Effect Market Outlook, By Voice Assistants (2024-2032) ($MN)
  • Table 10 Global Digital Placebo Effect Market Outlook, By AI/LLM-based Companions (2024-2032) ($MN)
  • Table 11 Global Digital Placebo Effect Market Outlook, By Immersive & Multisensory (2024-2032) ($MN)
  • Table 12 Global Digital Placebo Effect Market Outlook, By Virtual Reality (VR) (2024-2032) ($MN)
  • Table 13 Global Digital Placebo Effect Market Outlook, By Audio-visual Neuromodulation Tools (2024-2032) ($MN)
  • Table 14 Global Digital Placebo Effect Market Outlook, By Augmented/Mixed Reality (AR/MR) (2024-2032) ($MN)
  • Table 15 Global Digital Placebo Effect Market Outlook, By Wearables & Biofeedback (2024-2032) ($MN)
  • Table 16 Global Digital Placebo Effect Market Outlook, By Wrist & Ring Devices (2024-2032) ($MN)
  • Table 17 Global Digital Placebo Effect Market Outlook, By Neurofeedback/HRV Tools (2024-2032) ($MN)
  • Table 18 Global Digital Placebo Effect Market Outlook, By Haptics & TENS-like Consumer Devices (2024-2032) ($MN)
  • Table 19 Global Digital Placebo Effect Market Outlook, By Placebo Controls for Trials (2024-2032) ($MN)
  • Table 20 Global Digital Placebo Effect Market Outlook, By Sham App Conditions (2024-2032) ($MN)
  • Table 21 Global Digital Placebo Effect Market Outlook, By Expectancy-Matched Protocols (2024-2032) ($MN)
  • Table 22 Global Digital Placebo Effect Market Outlook, By Attentional Control Interfaces (2024-2032) ($MN)
  • Table 23 Global Digital Placebo Effect Market Outlook, By Technology (2024-2032) ($MN)
  • Table 24 Global Digital Placebo Effect Market Outlook, By Digital Modalities (2024-2032) ($MN)
  • Table 25 Global Digital Placebo Effect Market Outlook, By Mobile health apps (2024-2032) ($MN)
  • Table 26 Global Digital Placebo Effect Market Outlook, By Wearable devices and biosensors (2024-2032) ($MN)
  • Table 27 Global Digital Placebo Effect Market Outlook, By Telemedicine platforms (2024-2032) ($MN)
  • Table 28 Global Digital Placebo Effect Market Outlook, By Immersive Tech Stack (2024-2032) ($MN)
  • Table 29 Global Digital Placebo Effect Market Outlook, By VR/AR hardware (2024-2032) ($MN)
  • Table 30 Global Digital Placebo Effect Market Outlook, By Neuromodulation interfaces (2024-2032) ($MN)
  • Table 31 Global Digital Placebo Effect Market Outlook, By Behavioral Design (2024-2032) ($MN)
  • Table 32 Global Digital Placebo Effect Market Outlook, By Gamification (2024-2032) ($MN)
  • Table 33 Global Digital Placebo Effect Market Outlook, By Feedback loops (2024-2032) ($MN)
  • Table 34 Global Digital Placebo Effect Market Outlook, By Reinforcement systems (2024-2032) ($MN)
  • Table 35 Global Digital Placebo Effect Market Outlook, By AI Personalization (2024-2032) ($MN)
  • Table 36 Global Digital Placebo Effect Market Outlook, By Adaptive algorithms (2024-2032) ($MN)
  • Table 37 Global Digital Placebo Effect Market Outlook, By Expectancy modeling (2024-2032) ($MN)
  • Table 38 Global Digital Placebo Effect Market Outlook, By NLP-based tailoring (2024-2032) ($MN)
  • Table 39 Global Digital Placebo Effect Market Outlook, By Delivery Channel (2024-2032) ($MN)
  • Table 40 Global Digital Placebo Effect Market Outlook, By App-based interventions (2024-2032) ($MN)
  • Table 41 Global Digital Placebo Effect Market Outlook, By Chatbot/SMS-based (2024-2032) ($MN)
  • Table 42 Global Digital Placebo Effect Market Outlook, By Web-based platforms (2024-2032) ($MN)
  • Table 43 Global Digital Placebo Effect Market Outlook, By Immersive Interfaces (2024-2032) ($MN)
  • Table 44 Global Digital Placebo Effect Market Outlook, By Application (2024-2032) ($MN)
  • Table 45 Global Digital Placebo Effect Market Outlook, By Mental health (2024-2032) ($MN)
  • Table 46 Global Digital Placebo Effect Market Outlook, By Chronic pain management (2024-2032) ($MN)
  • Table 47 Global Digital Placebo Effect Market Outlook, By Sleep and stress interventions (2024-2032) ($MN)
  • Table 48 Global Digital Placebo Effect Market Outlook, By Cognitive enhancement (2024-2032) ($MN)
  • Table 49 Global Digital Placebo Effect Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 50 Global Digital Placebo Effect Market Outlook, By End User (2024-2032) ($MN)
  • Table 51 Global Digital Placebo Effect Market Outlook, By Patients & Consumers (2024-2032) ($MN)
  • Table 52 Global Digital Placebo Effect Market Outlook, By Healthcare providers (2024-2032) ($MN)
  • Table 53 Global Digital Placebo Effect Market Outlook, By Research institutions (2024-2032) ($MN)
  • Table 54 Global Digital Placebo Effect Market Outlook, By Payers and insurers (2024-2032) ($MN)
  • Table 55 Global Digital Placebo Effect Market Outlook, By CROs & Pharma (2024-2032) ($MN)
  • Table 56 Global Digital Placebo Effect Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.